A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)

The International Early Lung Cancer Action Program Investigators

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Background: The low-dose CT (≤3 mGy) screening report of 1000 Early Lung Cancer Action Program (ELCAP) participants in 1999 led to the International ELCAP (I-ELCAP) collaboration, which enrolled 31 567 participants in annual low-dose CT screening between 1992 and 2005. In 2006, I-ELCAP investigators reported the 10-year lung cancer.specific survival of 80% for 484 participants diagnosed with a first primary lung cancer through annual screening, with a high frequency of clinical stage I lung cancer (85%). Purpose: To update the cure rate by determining the 20-year lung cancer.specific survival of participants diagnosed with first primary lung cancer through annual low-dose CT screening in the expanded I-ELCAP cohort. Materials and Methods: For participants enrolled in the HIPAA-compliant prospective I-ELCAP cohort between 1992 and 2022 and observed until December 30, 2022, Kaplan-Meier survival analysis was used to determine the 10- and 20-year lung cancer.specific survival of participants diagnosed with first primary lung cancer through annual low-dose CT screening. Eligible participants were aged at least 40 years and had current or former cigarette use or had never smoked but had been exposed to secondhand tobacco smoke. Results: Among 89 404 I-ELCAP participants, 1257 (1.4%) were diagnosed with a first primary lung cancer (684 male, 573 female; median age, 66 years; IQR, 61.72), with a median smoking history of 43.0 pack-years (IQR, 29.0.60.0). Median follow-up duration was 105 months (IQR, 41.182). The frequency of clinical stage I at pretreatment CT was 81% (1017 of 1257). The 10-year lung cancer.specific survival of 1257 participants was 81% (95% CI: 79, 84) and the 20-year lung cancer.specific survival was 81% (95% CI: 78, 83), and it was 95% (95% CI: 91, 98) for 181 participants with pathologic T1aN0M0 lung cancer. Conclusion: The 10-year lung cancer.specific survival of 80% reported in 2006 for I-ELCAP participants enrolled in annual low-dose CT screening and diagnosed with a first primary lung cancer has persisted, as shown by the updated 20-year lung cancer.specific survival for the expanded I-ELCAP cohort.

Original languageAmerican English
Article numbere231988
JournalRadiology
Volume309
Issue number2
DOIs
StatePublished - Nov 2023

Bibliographical note

Publisher Copyright:
© 2023 RSNA.

Fingerprint

Dive into the research topics of 'A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)'. Together they form a unique fingerprint.

Cite this